Literature DB >> 17205374

Feature-map vectors: a new class of informative descriptors for computational drug discovery.

Gregory A Landrum1, Julie E Penzotti, Santosh Putta.   

Abstract

In order to develop robust machine-learning or statistical models for predicting biological activity, descriptors that capture the essence of the protein-ligand interaction are required. In the absence of structural information from X-ray or NMR experiments, deriving informative descriptors can be difficult. We have developed feature-map vectors (FMVs), a new class of descriptors based on chemical features, to address this challenge. FMVs, which are derived from the conformational models of a few actives, are low dimensional, problem specific, and highly interpretable. By using shape-based alignments and scoring with chemical features, FMVs can combine information about a molecule's shape and the pharmacophores it can match. In five validation studies, bag classifiers built using FMVs have shown high enrichments for identifying actives for five diverse targets: CDK2, 5-HT(3), DHFR, thrombin, and ACE. The interpretability of these descriptors has been demonstrated for CDK2 and 5-HT(3), where the method automatically discovers the standard literature pharmacophore.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205374     DOI: 10.1007/s10822-006-9085-8

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  37 in total

1.  Combination of a naive Bayes classifier with consensus scoring improves enrichment of high-throughput docking results.

Authors:  Anthony E Klon; Meir Glick; John W Davies
Journal:  J Med Chem       Date:  2004-08-26       Impact factor: 7.446

2.  Angiotensin-converting enzyme and male fertility.

Authors:  J R Hagaman; J S Moyer; E S Bachman; M Sibony; P L Magyar; J E Welch; O Smithies; J H Krege; D A O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis.

Authors:  H N Bramson; J Corona; S T Davis; S H Dickerson; M Edelstein; S V Frye; R T Gampe; P A Harris; A Hassell; W D Holmes; R N Hunter; K E Lackey; B Lovejoy; M J Luzzio; V Montana; W J Rocque; D Rusnak; L Shewchuk; J M Veal; D H Walker; L F Kuyper
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

4.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

5.  Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.

Authors:  V Cody; N Galitsky; J R Luft; W Pangborn; R L Blakley; A Gangjee
Journal:  Anticancer Drug Des       Date:  1998-06

6.  Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimisation of substituted 4,6-bis anilino pyrimidines.

Authors:  John F Beattie; Gloria A Breault; Rebecca P A Ellston; Stephen Green; Philip J Jewsbury; Catherine J Midgley; Russell T Naven; Claire A Minshull; Richard A Pauptit; Julie A Tucker; J Elizabeth Pease
Journal:  Bioorg Med Chem Lett       Date:  2003-09-15       Impact factor: 2.823

7.  Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidines.

Authors:  Gloria A Breault; Rebecca P A Ellston; Stephen Green; S Russell James; Philip J Jewsbury; Catherine J Midgley; Richard A Pauptit; Claire A Minshull; Julie A Tucker; J Elizabeth Pease
Journal:  Bioorg Med Chem Lett       Date:  2003-09-15       Impact factor: 2.823

8.  Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationships.

Authors:  Jeffrey J Sutherland; Lee A O'Brien; Donald F Weaver
Journal:  J Chem Inf Comput Sci       Date:  2003 Nov-Dec

9.  2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists.

Authors:  R D Clark; A B Miller; J Berger; D B Repke; K K Weinhardt; B A Kowalczyk; R M Eglen; D W Bonhaus; C H Lee; A D Michel
Journal:  J Med Chem       Date:  1993-09-03       Impact factor: 7.446

10.  Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.

Authors:  Vivian Cody; Joe R Luft; Walt Pangborn; Aleem Gangjee; Sherry F Queener
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-03-23
View more
  3 in total

1.  Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow.

Authors:  Chenglong Xie; Xu-Xu Zhuang; Zhangming Niu; Ruixue Ai; Sofie Lautrup; Shuangjia Zheng; Yinghui Jiang; Ruiyu Han; Tanima Sen Gupta; Shuqin Cao; Maria Jose Lagartos-Donate; Cui-Zan Cai; Li-Ming Xie; Domenica Caponio; Wen-Wen Wang; Tomas Schmauck-Medina; Jianying Zhang; He-Ling Wang; Guofeng Lou; Xianglu Xiao; Wenhua Zheng; Konstantinos Palikaras; Guang Yang; Kim A Caldwell; Guy A Caldwell; Han-Ming Shen; Hilde Nilsen; Jia-Hong Lu; Evandro F Fang
Journal:  Nat Biomed Eng       Date:  2022-01-06       Impact factor: 29.234

2.  Deep Generative Models for 3D Linker Design.

Authors:  Fergus Imrie; Anthony R Bradley; Mihaela van der Schaar; Charlotte M Deane
Journal:  J Chem Inf Model       Date:  2020-04-02       Impact factor: 4.956

3.  On the Value of Using 3D Shape and Electrostatic Similarities in Deep Generative Methods.

Authors:  Giovanni Bolcato; Esther Heid; Jonas Boström
Journal:  J Chem Inf Model       Date:  2022-03-10       Impact factor: 4.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.